This printed article is located at https://tih.listedcompany.com/news.html
| Announcement Title | Change - Announcement of Appointment |
| Date & Time of Broadcast | Sep 17, 2020 17:18 |
| Status | New |
| Announcement Sub Title | Appointment of Alternate Director |
| Announcement Reference | SG200917OTHRRXR7 |
| Submitted By (Co./ Ind. Name) | Lee Hock Heng |
| Designation | Company Secretary |
| Description (Please provide a detailed description of the event in the box below) | Please refer to the attachment. |
| Additional Details | |
| Date Of Appointment | 18/09/2020 |
| Name Of Person | Abram Melkyzedeck Suhardiman |
| Age | 31 |
| Country Of Principal Residence | Singapore |
| The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) | The Nominating Committee and the Board of Directors, having considered the qualification, experience and suitability of Mr Abram Melkyzedeck Suhardiman, is satisfied that Mr Abram Melkyzedeck Suhardiman possesses the requisite qualifications and work experience to be appointed as the alternate to Mr Alex Shiu Leung Au. On the recommendation by the Nominating Committee, the Board approved the appointment of Mr Abram Melkyzedeck Suhardiman as a Non-Executive Director, alternate to Mr Alex Shiu Leung Au. |
| Whether appointment is executive, and if so, the area of responsibility | Non-Executive |
| Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Non-Executive Director, alternate to Mr Alex Shiu Leung Au |
| Professional qualifications | Masters Program in Finance, Hult International Business School, San Francisco, CA, USA, 2012 Bachelor of Science in Business Administration, University of Southern California, Los Angeles, CA, USA, 2010 |
| Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries | Son-in-law of Dr Stephen Riady, a substantial shareholder of the Company |
| Conflict of interests (including any competing business) | No |
| Working experience and occupation(s) during the past 10 years | 2020 to Present Deputy CEO of Healthway Medical Corporation Limited 2019 to Present Executive Director of Healthway Medical Corporation Limited 2017 to 2020 Chief Operating Officer of Healthway Medical Corporation Limited 2015 to 2017 Vice President, Business Development & Investor Relations, Nuvest Capital 2013 to 2015 Analyst, The Abraaj Group 2012 to 2013 Business Development Manager, PT Artha Cipta Langgeng 2010 to 2011 Intern, Citibank N.A. |
| Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6)) | Yes |
| Shareholding interest in the listed issuer and its subsidiaries? | No |
| # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8). | |
| Past (for the last 5 years) | Nuvest Real Return Fund |
| Present | Healthway Medical Corporation Limited City Ocean Group Limited |
| (a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? | No |
| (b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? | No |
| (c) Whether there is any unsatisfied judgment against him? | No |
| (d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? | No |
| (e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? | No |
| (f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? | No |
| (g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? | No |
| (h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? | No |
| (i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? | No |
| (j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :- | |
| (i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or | No |
| (ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or | No |
| (iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or | No |
| (iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? | No |
| (k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? | No |
| Any prior experience as a director of an issuer listed on the Exchange? | Yes |
| If Yes, Please provide details of prior experience | Executive Director & Deputy CEO of Healthway Medical Corporation Limited |
| Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable) | N.A. |
Attachments